Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 569

Carta to compete in corporate venturing

Carta Ventures will invest in startups developing technology of strategic interest to its parent, which is preparing for the launch of a trading platform later this year.

Feb 11, 2020

Sonoma sends for Lyell in $40m series A

Sonoma Biotherapeutics has emerged from stealth with $40m to develop regulatory T-cell therapies for autoimmune and degenerative diseases.

Feb 10, 2020

Snowflake falls for Salesforce in $479m round

Salesforce Ventures took part in a round that valued the cloud data analytics platform at $12.4bn, pushing its overall funding past $1.3bn.

Feb 10, 2020

Sonoma sends for Lyell in $40m series A

Sonoma Biotherapeutics has emerged from stealth with $40m from investors including Lyell Immunopharma and is developing regulatory T-cell therapies for autoimmune and degenerative diseases.

Feb 10, 2020

HopSkipDrive picks up $22m

State Farm Ventures backed a round that will help HopSkipDrive expand across the US and add safety features to its children's ride-sharing service.

Feb 10, 2020

Corporate venturing deal net: 3-7 February 2020

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Feb 7, 2020

Daily deal net: February 7, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Feb 7, 2020

Netskope catches $340m

The Dell-backed cloud security platform developer was valued at nearly $3bn in a late-stage round led by Sequoia Capital Global Equities.

Feb 7, 2020

Lange lunges into PRF position

Wade Lange is Purdue Research Foundation's new vice-president and chief entrepreneurial officer, having previously served as Purdue Foundry's entrepreneur-in-residence.

Feb 7, 2020

Schrödinger shakes out $202m from IPO

The GV and Wuxi AppTec-backed drug development software producer floated above its range and saw its shares rise 68% on their first day of trading.

Feb 7, 2020
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here